GROWTH-INHIBITION AND INDUCTION OF DIFFERENTIATION OF T(821) ACUTE MYELOID-LEUKEMIA CELLS BY THE DNA-BINDING DOMAIN OF PEBP2 AND THE AML1/MTG8(ETO)-SPECIFIC ANTISENSE OLIGONUCLEOTIDE

被引:97
作者
SAKAKURA, C
YAMAGUCHIIWAI, Y
SATAKE, M
BAE, SC
TAKAHASHI, A
OGAWA, E
HAGIWARA, A
TAKAHASHI, T
MURAKAMI, A
MAKINO, K
NAKAGAWA, T
KAMADA, N
ITO, Y
机构
[1] KYOTO UNIV,INST VIRUS RES,DEPT VIRAL ONCOL,SAKYO KU,KYOTO 606,JAPAN
[2] KYOTO PREFECTURAL UNIV MED,DEPT SURG 1,KAMIGYO KU,KYOTO 602,JAPAN
[3] KYOTO INST TECHNOL,DEPT POLYMER SCI & ENGN,SAKYO KU,KYOTO 606,JAPAN
[4] HYOGO MED CTR,AKASHI,HYOGO 673,JAPAN
[5] RES INST NUCL MED & BIOL,DEPT HEMATOL,MINAMI KU,HIROSHIMA 734,JAPAN
关键词
D O I
10.1073/pnas.91.24.11723
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
The translocation from chromosome 8 to chromosome 21, t(8;21), associated with acute myeloid leukemia results in production of an AML1/MTG8(ETO) fusion transcript. The product of the AML1 gene contains an evolutionarily conserved 128-amino acid region referred to as the ''Runt domain,'' which is necessary for binding to DNA at the PEBP2 site. A fragment of the AML1 protein containing mainly the Runt domain and the antisense oligonucleotide complementary to the fusion transcript strongly inhibited the growth and induced differentiation of cell lines derived from acute myeloid leukemia containing t(8;21). These results indicate that the transcriptional regulation through the PEBP2 site is critically important for growth and differentiation of t(8;21) leukemic cells and that the product of the chimeric gene is responsible for the maintenance of the leukemic phenotype.
引用
收藏
页码:11723 / 11727
页数:5
相关论文
共 36 条
[1]  
ASOU H, 1991, BLOOD, V77, P2031
[2]  
BAE SC, 1993, ONCOGENE, V8, P809
[3]   PEBP2-ALPHA-B/MOUSE AML1 CONSISTS OF MULTIPLE ISOFORMS THAT POSSESS DIFFERENTIAL TRANSACTIVATION POTENTIALS [J].
BAE, SC ;
OGAWA, E ;
MARUYAMA, M ;
OKA, H ;
SATAKE, M ;
SHIGESADA, K ;
JENKINS, NA ;
GILBERT, DJ ;
COPELAND, NG ;
ITO, Y .
MOLECULAR AND CELLULAR BIOLOGY, 1994, 14 (05) :3242-3252
[4]   INDUCTION OF DIFFERENTIATION OF THE HUMAN PROMYELOCYTIC LEUKEMIA-CELL LINE (HL-60) BY RETINOIC ACID [J].
BREITMAN, TR ;
SELONICK, SE ;
COLLINS, SJ .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA-BIOLOGICAL SCIENCES, 1980, 77 (05) :2936-2940
[5]   ONCOGENIC CONVERSION OF TRANSCRIPTION FACTORS BY CHROMOSOMAL TRANSLOCATIONS [J].
CLEARY, ML .
CELL, 1991, 66 (04) :619-622
[6]   CONTINUOUS GROWTH AND DIFFERENTIATION OF HUMAN MYELOID LEUKEMIC-CELLS IN SUSPENSION CULTURE [J].
COLLINS, SJ ;
GALLO, RC ;
GALLAGHER, RE .
NATURE, 1977, 270 (5635) :347-349
[7]  
ERIKSON P, 1992, BLOOD, V80, P1825
[8]   THE ACUTE PROMYELOCYTIC LEUKEMIA-SPECIFIC PML-RAR-ALPHA FUSION PROTEIN INHIBITS DIFFERENTIATION AND PROMOTES SURVIVAL OF MYELOID PRECURSOR CELLS [J].
GRIGNANI, F ;
FERRUCCI, PF ;
TESTA, U ;
TALAMO, G ;
FAGIOLI, M ;
ALCALAY, M ;
MENCARELLI, A ;
GRIGNANI, F ;
PESCHLE, C ;
NICOLETTI, I ;
PELICCI, PG .
CELL, 1993, 74 (03) :423-431
[9]   ACUTE-LEUKEMIA IN BCR/ABL TRANSGENIC MICE [J].
HEISTERKAMP, N ;
JENSTER, G ;
TENHOEVE, J ;
ZOVICH, D ;
PATTENGALE, PK ;
GROFFEN, J .
NATURE, 1990, 344 (6263) :251-253
[10]   THE RUNT DOMAIN IDENTIFIES A NEW FAMILY OF HETEROMERIC TRANSCRIPTIONAL REGULATORS [J].
KAGOSHIMA, H ;
SHIGESADA, K ;
SATAKE, M ;
ITO, Y ;
MIYOSHI, H ;
OHKI, M ;
PEPLING, M ;
GERGEN, P .
TRENDS IN GENETICS, 1993, 9 (10) :338-341